
Explore novel C0702 restricted epitope on MAGE A1 and its preclinical development for enhanced anti-tumor T-cell responses in cancer immunotherapy.

Explore novel CAR-T cell engineering using piggyBac transposon for solid tumors. Learn about memory-rich T cells, manufacturing processes, and potential clinical applications in cancer immunotherapy.

Explore ecological dynamics in cancer-immune interactions, focusing on evolution, complex systems, and immunotherapy. Gain insights into genome instability and adaptive immune responses.

Explore pre-clinical research on a novel PD-L1 B cell epitope peptide vaccine, PDL1-Vaxx, presented by Jay Overholser from Ohio State University Wexner Medical Center.

Explore hypoxia biomarkers for personalized cancer treatments. Learn about tumor microenvironments, prognosis impacts, and treatment resistance. Gain insights into targeting hypoxia for improved patient outcomes.

Investigates heat therapy's impact on inosine production and its potential influence on tumor recurrence, offering insights into innovative cancer treatment approaches.

Explore optimal control strategies for combination immunotherapy in glioblastoma treatment using mathematical modeling and virtual murine cohorts.

Explore experimental-computational integration to understand tumor characteristics and their impact on treatment effectiveness.

Explore methods for determining causation in immunotherapy, focusing on analytical techniques and challenges in evaluating treatment effectiveness.

Explore a mathematical model for TCR-T cell therapy in cervical cancer treatment, focusing on its applications and implications in oncology research.

Explore the latest advancements in antibody-drug conjugates (ADCs) for treating non-small cell lung cancer, focusing on their efficacy, safety, and potential to revolutionize NSCLC therapy.

Explore updated guidelines for treating relapsed/refractory multiple myeloma, enhancing patient care with the latest therapeutic approaches and clinical insights.

Explore cutting-edge adjuvant and targeted therapies for endometrial cancer, focusing on recent advancements in front-line treatment approaches.

Explore the role of exhausted T cells and immune checkpoints in cancer, with insights relevant to USMLE preparation.

Explore cutting-edge nanocarrier designs for targeted cancer therapy, focusing on ovarian cancer treatment and innovative drug delivery mechanisms.

Explore innovative cancer immunotherapy techniques using anchored cytokines, as presented by MIT's K. Dane Wittrup in this bioengineering seminar.

Explore how lifestyle changes can impact cancer's metabolic pathways with insights from a cancer survivor and former pilot who revolutionized his approach to the disease.

Explore immunological reset, B cell depletion, CAR T therapy, and precision immunotherapies for scleroderma treatment with expert insights on current and future approaches.

Explore neoantigen identification and vaccine design through bioinformatics. Learn about REAL-neo analytic framework and novel modules for tumor sequencing data analysis in immunotherapy research.

Explore cutting-edge proteomics techniques for mapping cell-to-cell communication in cancer immunology, focusing on immune checkpoints and their potential in immunotherapy.

Explore innovative approaches to teaching math through real-world applications in cancer treatment, data modeling, and error analysis with Helen Moore.